These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 19123981)

  • 1. Imaging of cardiotoxicity.
    Glickson JD; Forder JR; Chatham JC
    Mol Imaging; 2008; 7(3):115-7. PubMed ID: 19123981
    [No Abstract]   [Full Text] [Related]  

  • 2. Imaging of early modification in cardiomyopathy: the doxorubicin-induced model.
    Aissiou M; Périé D; Cheriet F; Dahdah NS; Laverdière C; Curnier D
    Int J Cardiovasc Imaging; 2013 Oct; 29(7):1459-76. PubMed ID: 23744127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viewpoint: the way forward in cardiac imaging.
    Gutberlet M
    Circulation; 2006 Aug; 114(5):f117-8. PubMed ID: 16883649
    [No Abstract]   [Full Text] [Related]  

  • 4. Anthracycline cardiotoxicity: recognition, management, and avoidance.
    Mason JW
    Compr Ther; 1979 Jul; 5(7):64-8. PubMed ID: 477286
    [No Abstract]   [Full Text] [Related]  

  • 5. Heart rate dynamics in doxorubicin-induced cardiomyopathy.
    Lončar-Turukalo T; Vasić M; Tasić T; Mijatović G; Glumac S; Bajić D; Japunžić-Žigon N
    Physiol Meas; 2015 Apr; 36(4):727-39. PubMed ID: 25798626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adriamycin cardiotoxicity.
    Bristow MR; Billingham ME; Mason JW
    Am J Cardiol; 1984 Jan; 53(1):263-4. PubMed ID: 6691272
    [No Abstract]   [Full Text] [Related]  

  • 7. Adriamycin cardiotoxicity monitoring by radionuclide scan.
    Robinson BA; Colls BM; Turner JG
    Br J Cancer; 1983 Aug; 48(2):315-7. PubMed ID: 6882671
    [No Abstract]   [Full Text] [Related]  

  • 8. Doxorubicin-induced cardiomyopathy: from molecular mechanisms to therapeutic strategies.
    Octavia Y; Tocchetti CG; Gabrielson KL; Janssens S; Crijns HJ; Moens AL
    J Mol Cell Cardiol; 2012 Jun; 52(6):1213-25. PubMed ID: 22465037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental animal models of adriamycin cardiotoxicity.
    Doroshow JH; Locker GY; Myers CE
    Cancer Treat Rep; 1979 May; 63(5):855-60. PubMed ID: 110445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Doxorubicin-induced cardiomyopathy.
    Dunn J
    J Pediatr Oncol Nurs; 1994 Oct; 11(4):152-60. PubMed ID: 7946145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Appraising cardiotoxicity associated with liposomal doxorubicin by means of tissue Doppler echocardiography end-points: rationale and design of the LITE (Liposomal doxorubicin-Investigational chemotherapy-Tissue Doppler imaging Evaluation) randomized pilot study.
    Lotrionte M; Palazzoni G; Natali R; Comerci G; Abbate A; Di Persio S; Biondi-Zoccai GG
    Int J Cardiol; 2009 Jun; 135(1):72-7. PubMed ID: 18572266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cardiotoxicity of doxorubicin in children].
    Brockmeier FK
    Ned Tijdschr Geneeskd; 1984 Oct; 128(43):2063. PubMed ID: 6504200
    [No Abstract]   [Full Text] [Related]  

  • 13. Doxorubicin-induced cardiomyopathy.
    Ginsburg AD
    N Engl J Med; 1999 Feb; 340(8):654; author reply 655. PubMed ID: 10049086
    [No Abstract]   [Full Text] [Related]  

  • 14. Myocardial sympathetic dysinnervation in doxorubicin cardiomyopathy.
    Takano H; Ozawa H; Kobayashi I; Hamaoka S; Nakajima J; Nakamura T; Sato K; Kimura H; Naito A; Obata S; Koizumi K; Tamura K
    J Cardiol; 1996 Feb; 27(2):49-55. PubMed ID: 8919183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Doxorubicin cardiomyopathy.
    Tri TB; Wilkins J
    Ann Intern Med; 1978 Jul; 89(1):137. PubMed ID: 666160
    [No Abstract]   [Full Text] [Related]  

  • 16. Doxorubicin-induced cardiomyopathy.
    Singal PK; Iliskovic N
    N Engl J Med; 1998 Sep; 339(13):900-5. PubMed ID: 9744975
    [No Abstract]   [Full Text] [Related]  

  • 17. [Usefulness of 123I-MIBG myocardial SPECT in patients with hematologic malignancies with chemotherapeutic agent-induced cardiomyopathy].
    Niitsu N; Yamazaki J; Nakayama M; Umeda M; Morishita T
    Gan To Kagaku Ryoho; 1995 Nov; 22(13):1941-5. PubMed ID: 7487124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cardiotoxicity of adriamycin].
    Mordeglia F; Mirassou C
    Medicina (B Aires); 1979; 39(3):423-5. PubMed ID: 514062
    [No Abstract]   [Full Text] [Related]  

  • 19. Doxorubicin-induced cardiotoxicity: from bioenergetic failure and cell death to cardiomyopathy.
    Carvalho FS; Burgeiro A; Garcia R; Moreno AJ; Carvalho RA; Oliveira PJ
    Med Res Rev; 2014 Jan; 34(1):106-35. PubMed ID: 23494977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in fatty acid metabolic disorder between ischemic myocardium and doxorubicin-induced myocardial damage: assessment using BMIPP dynamic SPECT with analysis by the Rutland method.
    Kitagawa K; Takeda K; Saito K; Okamoto S; Makino K; Maeda H; Ichihara T
    J Nucl Med; 2002 Oct; 43(10):1286-94. PubMed ID: 12368365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.